The Effect of Nasal Carbon Dioxide (CO2) Used As-Needed in the Symptomatic Treatment of Seasonal Allergic Rhinitis
NCT00917020
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG:
Nasal CO2
DRUG:
Inactive Placebo Gas
Sponsor
Capnia, Inc.